RoboticsConfidence BUnited Statesactive

GEn1E Lifesciences

AI platform accelerating therapies for rare & inflammatory diseases.

Official websitegen1e.com
RegionPalo Alto, United States
CategoryRobotics / Embodied AI
Funding statusUnknown · Undisclosed
Last updatedJun 11, 2026
Latest signalJun 11, 2026

Status timeline

Funding, product, customer, team, and correction signals
Jun 10, 2026Confidence A
Product0 evidence links

GEn1E Lifesciences product scope reviewed

GEn1E Lifesciences public product source reviewed for category placement and current operating focus.

No source evidence matched to this event.
Jun 10, 2026Confidence B
Funding0 evidence links

GEn1E Lifesciences capital or status signal reviewed

GEn1E Lifesciences public source reviewed for capital or strategic-status timeline signal.

No source evidence matched to this event.

Funding timeline

Amounts are shown only when disclosed and tied to evidence.
Jun 10, 2026

Unknown

AmountUndisclosed
InvestorsY Combinator profile
EvidenceConfidence B
No source evidence matched to this round.

Source evidence

Public links, short factual summaries, and trust levels

GEn1E Lifesciences official product profile

GEn1E Lifesciences official site · official
Confidence A

GEn1E Lifesciences official source reviewed for product scope, operating focus, and category placement.

Trust APublic review
Open source

GEn1E Lifesciences capital or status signal

Y Combinator Startup Directory · registry
Confidence B

GEn1E Lifesciences public capital or strategic-status source reviewed for stage and timeline signal.

Trust BPublic review
Open source

Similar projects

Same category or overlapping tags